Scott Henry
Stock Analyst at Alliance Global Partners
(1.28)
# 3,633
Out of 5,180 analysts
60
Total ratings
36.96%
Success rate
-6.02%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.73 | +313.45% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $0.77 | +384.50% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $1.18 | +408.47% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $7.99 | +25.16% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $19.06 | +116.42% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $4.69 | +81.24% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.01 | +296.04% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $2.79 | +437.63% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $240 | $0.73 | +32,790.23% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $5.84 | +28.42% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.28 | +40.09% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $32.54 | -26.24% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $199.65 | -54.92% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $24.76 | -37.40% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $109.17 | -46.87% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $96.17 | -62.57% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.02 | +978.43% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.98 | +50.75% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $0.64 | +891,511.10% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.17 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.68 | +936.12% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $13.75 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.49 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.73
Upside: +313.45%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $0.77
Upside: +384.50%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $1.18
Upside: +408.47%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $7.99
Upside: +25.16%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $19.06
Upside: +116.42%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $4.69
Upside: +81.24%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.01
Upside: +296.04%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $2.79
Upside: +437.63%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $240
Current: $0.73
Upside: +32,790.23%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $5.84
Upside: +28.42%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $9.28
Upside: +40.09%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $32.54
Upside: -26.24%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $199.65
Upside: -54.92%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $24.76
Upside: -37.40%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $109.17
Upside: -46.87%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $96.17
Upside: -62.57%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.02
Upside: +978.43%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.98
Upside: +50.75%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $0.64
Upside: +891,511.10%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.17
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.68
Upside: +936.12%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $13.75
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.49
Upside: -